Skip to main content

Table 1 Population and tumor samples characteristics

From: PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

 

N (%)

Age (years)

 

 · Median (range)

68 (45–87)

Gender

 

 · Female

34 (37.0%)

 · Male

58 (63.0%)

Primary tumor location

 

 · Right colon

27 (29.3%)

 · Transverse colon

5 (5.4%)

 · Left colon

9 (9.8%)

 · Sigmoid colon

18 (19.6%)

 · Recto sigmoid colon

14 (15.2%)

 · Rectum

19 (20.7%)

Histology

 

 · Conventional adenocarcinoma

79 (85.9%)

 · Mucinous or colloid adenocarcinoma

12 (13.0%)

 · Signet ring cell adenocarcinoma

1 (1.1%)

Tumor differentiation

 

 · Well differentiated

22 (23.9%)

 · Moderately differentiated

46 (50.0%)

 · Poorly differentiated

12 (13.0%)

TNM stage

 

 · I

8 (8.7%)

 · II

22 (23.9%)

 · III

24 (26.1%)

 · IV

37 (40.2%)

 · Unknown

1 (1.1%)

Baseline CEA (ng/mL)

 

 · High

33 (35.9%)

 · Normal

59 (64.1%)

 · Median (range)

3 (0–13.318)

  1. TNM: Tumor, Node and Metastases; CEA: carcinoembryonic antigen.